Role of glutathione conjugation in protection of weanling rat liver against acetaminophen-induced hepatotoxicity

Mechanisms of Ageing and Development

Volumn 95, Issue 1-2, 1997, Pages 71-79

  Allameh, Abdolamir ^a   Vansoun, Emelin Y ^b   Zarghi, Afshin ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acetaminophen; Glutathione conjugation; N acetylcystein; Weanling rat

Indexed keywords

ACETYLCYSTEINE; GLUTATHIONE; PARACETAMOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONJUGATION; CONTROLLED STUDY; CYTOSOL; DETOXIFICATION; GLUTATHIONE METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETAMINOPHEN; ACETYLCYSTEINE; AGING; ANALGESICS, NON-NARCOTIC; ANIMALS; GLUTATHIONE; LIVER; MALE; METABOLIC DETOXICATION, DRUG; RATS;

ANIMALIA;

EID: 0030915474     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(97)01862-9     Document Type: Article

References (25)

1. T.D. Boyer and L.J. Rouffs, Acetaminophen-induced hepatic necrosis and renal failure. J. Am. Med. Assoc., 218 (1971) 440-441.
2. N.P.E. Vermeulen, R.G.M. Bassems and R. Van Der Straat, Molecular aspects of paracetamol-induced hepatotoxicity and mechanism-based prevention. Drug Met. Rev., 24 (1992) 367-407.
3. R.P. Miller, R.J. Roberts and L.J. Fischer, Acetaminophen elimination kinetics in neonates, children and adults. Clin. Pharmacol. Ther., 19 (1975) 285-294.
4. R.J. Mitchell, D.J. Jollow, W.Z. Potter, C.C. Davies, J.R. Gillette and B.B. Brodie, Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J. Pharmacol. Exp. Ther., 187 (1973) 185-194.
5. D.J. Jollow, J.R. Mitchell, W.Z. Potter, C.C. Davies, J.R. Gillette and B.B. Brodie, Acetaminophen-induced hepatic necrosis. II.Role of covalent binding in vivo. J. Pharmacol. Exp. Ther., 187 (1973) 195-202.
6. J.R. Mitchell, H. Hughes, B.H. Lauterburg and C.V. Smith, Chemical nature of reactive intermediates as a determinant of toxicological responses. Drug Metab. Rev., 13 (1982) 539-553.
7. J.A. Hinson, N.R. Pumford and S.D. Nelson, The role of metabolic activation in drug toxicity. Drug Metab. Rev., 26 (1994) 395-412.
8. S.D. Nelson, Mechanisms of the formation and disposition of reactive metabolites that can cause acute liver injury. Drug Metab. Rev., 27 (1995) 147-177.
9. D.J. Jollow, Glutathione threshold in reactive metabolite toxicity. Arch. Toxicol., 3 (1980) 95-110.
10. B.H. Lauterburg and J.R. Mitchell. Toxic doses of acetaminophen supress hepatic glutathione synthesis in rats. Hepatology, 2 (1982) 8-12.
11. D.C. Davis, W.Z. Potter, D.J. Jollow and J.R. Mitchell, Species differences in hepatic glutathione depletion, covalent binding and hepatic necrosis after acetaminophen. Life Sci., 14 (1974) 2099-2109.
12. D. Labadarios, B. Davis, B. Portmann and R. Williams, Paracetamol-induced hepatic necrosis in the mouse. Relationship between covalent binding, hepatic glutathione depletion and the protective effect of alpha-mercaptopropionyl glycine. Biochem. Pharmacol., 26 (1977) 31-35.
13. J.G. Hart and J.A. Timbrell, The effect of age on paracetamol hepatotoxicity. Biochem. Pharmacol., 28 (1979) 3015-3017.
14. M.D. Green and L.J. Fischer, Hepatotoxicity of acetaminophen in neonatal and young rats. Toxicol. Appl. Pharmacol., 74 (1984) 125-133.
15. J. Sedlak, R.H. Lindsay, Estimation of total protein with bound and non-protein sulfhydryl groups in tissues with Ellman's reagent. Anal. Biochem., 25 (1968) 192-205.
16. A. Allameh, M. Saxena and H.G. Raj, Differential effects of butylated hydroxy-anisole on metabolism of aflatoxin B1 in vitro by liver and lung microsomes. Cancer Lett., 40 (1988) 49-57.
17. L.F. Prescott, Paracetamol overdosage; Pharmacological considerations and clinical management. Drugs, 25 (1983) 290-314.
18. A. Allameh, M. Saxena, L.M. Mehta and H.G. Raj, Comparison of pulmonary and hepatic glutathione depletion by diethyl maleate. Med. Sci. Res., 15 (1987) 957-958.
19. T.A. Smolarek, C.V. Higging and Amacher, Metabolism and cytotoxicity of acetaminophen in hepatocyte cultures from rat, rabbit, dog and monkey. Drug Metab. Dis., 18 (1990) 859-863.
20. G.H. Degan and H.G. Neumann, The major metabolite of aflatoxin B1 in the rat is a glutathione conjugate. Chemico. Biol. Interactions, 22 (1978) 239-255.
21. M. Polhuijs, G. Lankhaar and G.J. Mulder, Relationship between glutathione content in liver and glutathione conjugation in the rat in vivo. Biochem. J., 285 (1992) 401-404.
22. G.J. Dutton. Drug metabolism and development. In: C.T. Jones (ed.), Biochemical Development of the Fetus and Neonate, Elsevier, Amsterdam, 1982, pp. 823-840.
23. M. Behroozikha, M. Saidee and A. Allameh, Comparison of aflatoxin B1-DNA binding and glutathione conjugate formation by liver preparations from rats of different ages. Cancer Lett., 66 (1992) 69-76.
24. M. Chelcheleh and A. Allameh, In vivo biotransformation of aflatoxin B1 and its interaction with cellular macromolecules in neonatal rats. Mech. Ageing Dev., 78 (1995) 189-196.
25. R.E. Galinsky and G. Levy, Effect of N-acetylcystein on the pharmaco-kinetics of acetaminophen in rats. Life Sci., 25 (1979) 693-700.